Topic: How To Invest

TD Health Sciences Fund $15.69

TD HEALTH SCIENCES FUND $15.69 (CWA Rating: Speculative) (TD Asset Management, P.O. Box 7500, Station A, Toronto, Ontario. M5W 1P9. 1-800-463-3863; Web site: www.tdcanadatrust.ca. No load — deal directly with the bank) invests mostly in U.S. companies with a mixture of large-capitalization stocks and earlier-stage biotechnology shares. The fund’s managers believe all these firms will profit from an aging population stimulating higher spending by governments and individuals on health care, drugs and research.

The fund’s top holdings include Gilead Sciences, Alexion Pharmaceuticals, Elan Corp. plc, Baxter International, Genentech Inc., Biomarin Pharmaceutical, Wyeth, Monsanto Co., Illumina and Cephalon. The fund’s MER is 2.70%. The $170.3 million fund lost 7.4% over the last year.

TD Health Sciences Fund is still a buy.

Comments are closed.